Below are the most recent publications written about "Inflammatory Breast Neoplasms" by people in Profiles.
-
Valenza C, Trapani D, Zagami P, Antonarelli G, Boscolo Bielo L, Nicol? E, Ribeiro JM, Guidi L, Reduzzi C, Spotti M, Adamoli L, Cort?s J, Pistilli B, Tolaney SM, Ueno N, Layman RM, Cristofanilli M, Carey LA, Munzone E, Criscitiello C, Lynce F, Woodward WA, Curigliano G. Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study. Eur J Cancer. 2024 Dec; 213:115097.
-
Boussen H, Berrazaga Y, Manai M, Berrada N, Mejri N, Siala I, Levine PH, Cristofanilli M. Inflammatory breast cancer: Epidemiologic data and therapeutic results. Int Rev Cell Mol Biol. 2024; 384:1-23.
-
van Golen KL. Inflammatory breast cancer biomarkers and biology. Int Rev Cell Mol Biol. 2024; 384:63-76.
-
Foss HE, Bulafka J, Nwaoduah N, Shah MS. Bladder metastasis from inflammatory breast cancer presenting with hematuria and hydronephrosis. Can J Urol. 2023 12; 30(6):11747-11751.
-
Manai M, ELBini-Dhouib I, Finetti P, Bichiou H, Reduzzi C, Aissaoui D, Ben-Hamida N, Agavnian E, Srairi-Abid N, Lopez M, Amri F, Guizani-Tabbane L, Rahal K, Mrad K, Manai M, Birnbaum D, Mamessier E, Cristofanilli M, Boussen H, Kharrat M, Doghri R, Bertucci F. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. Cells. 2022 09 19; 11(18).
-
Gong Y, Nagarathinam R, Arisi MF, Gerratana L, Winn JS, Slifker M, Pei J, Cai KQ, Hasse Z, Obeid E, Noriega J, Sebastiano C, Ross E, Alpaugh K, Cristofanilli M, Fernandez SV. Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). Int J Mol Sci. 2021 Aug 19; 22(16).
-
Vagia E, Cristofanilli M. New Treatment Strategies for the Inflammatory Breast Cancer. Curr Treat Options Oncol. 2021 04 24; 22(6):50.
-
Fernandez SV, MacFarlane AW, Jillab M, Arisi MF, Yearley J, Annamalai L, Gong Y, Cai KQ, Alpaugh RK, Cristofanilli M, Campbell KS. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Res. 2020 12 02; 22(1):134.
-
Bertucci F, Rypens C, Finetti P, Guille A, Ad?la?de J, Monneur A, Carbuccia N, Garnier S, Dirix P, Gon?alves A, Vermeulen P, Debeb BG, Wang X, Dirix L, Ueno NT, Viens P, Cristofanilli M, Chaffanet M, Birnbaum D, Van Laere S. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. Mol Oncol. 2020 03; 14(3):504-519.
-
Romanoff A, Zabor EC, Petruolo O, Stempel M, El-Tamer M, Morrow M, Barrio AV. Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers? Cancer. 2018 11 15; 124(22):4314-4321.